PHQ 9 en FR

Download as pdf or txt
Download as pdf or txt
You are on page 1of 3
At a glance
Powered by AI
The document describes the Patient Health Questionnaire (PHQ-9), a common screening tool used to assess depression severity over the past 2 weeks. It lists 9 symptoms and asks how frequently the patient has been bothered by each in the past 2 weeks.

The PHQ-9 is assessing how frequently in the past 2 weeks a patient has experienced 9 common symptoms of depression like lack of interest, feeling down, trouble sleeping, fatigue, appetite changes, feelings of failure/guilt, concentration difficulties, psychomotor changes, and suicidal thoughts.

PHQ-9 scores are interpreted on a scale of 0-4 as normal, 5-9 as minimal symptoms, 10-14 as mild depression, 15-19 as moderate depression, and 20+ as severe depression. The scores can help determine treatment recommendations and monitor progress.

Patient Health Questionnaire (PHQ-9)

Patient name: __________________________________ Date: ___________________

1. Over the last 2 weeks, how often have you been bothered by any of the following problems?

More than Nearly


Not at all Several half the every day
(0) days (1) days (2) (3)

a. Little interest or pleasure in doing things.    

b. Feeling down, depressed, or hopeless.    

c. Trouble falling/staying asleep, sleeping too much.    

d. Feeling tired or having little energy.    

e. Poor appetite or overeating.    

f. Feeling bad about yourself, or that you are a


   
failure, or have let yourself or your family down.

g. Trouble concentrating on things, such as reading


   
the newspaper or watching TV.

h. Moving or speaking so slowly that other people


could have noticed.
   
Or the opposite; being so fidgety or restless that
you have been moving around more than usual.

i. Thoughts that you would be better off dead or of


   
hurting yourself in some way.

2. If you checked off any problem on this questionnaire so far, how difficult have these
problems made it for you to do your work, take care of things at home, or get along with
other people?

 Not difficult  Somewhat  Very  Extremely


at all difficult difficult difficult

TOTAL SCORE _________________

PHQ9 Copyright © Pfizer Inc. All rights reserved. Reproduced with permission.
PRIME-MD ® is a trademark of Pfizer Inc.
Instructions – How to Score the PHQ-9

Major depressive disorder is suggested if:


 Of the 9 items, 5 or more are checked as at least ‘more than half the days’
 Either item a. or b. is positive, that is, at least ‘more than half the days’

Other depressive syndrome is suggested if:


 Of the 9 items, a., b. or c. is checked as at least ‘more than half the days’
 Either item a. or b. is positive, that is, at least ‘more than half the days’

Also, PHQ-9 scores can be used to plan and monitor treatment. To score the instrument, tally
each response by the number value under the answer headings, (not at all=0, several days=1,
more than half the days=2, and nearly every day=3). Add the numbers together to total the score
on the bottom of the questionnaire. Interpret the score by using the guide listed below.

Guide for Interpreting PHQ-9 Scores

Score Recommended Actions


0-4 Normal range or full remission. The score suggests the patient may not need
depression treatment.
5-9 Minimal depressive symptoms. Support, educate, call if worse, return in 1
month.
10-14 Major depression, mild severity. Use clinical judgment about treatment, based
on patient’s duration of symptoms and functional impairment. Treat with
antidepressant or psychotherapy.
15-19 Major depression, moderate severity. Warrants treatment for depression, using
antidepressant, psychotherapy or a combination of treatment.
20 or Major depression, severe severity. Warrants treatment with antidepressant and
higher psychotherapy, especially if not improved on monotherapy; follow frequently.

Functional Health Assessment

The instrument also includes a functional health assessment. This asks the patient how emotional
difficulties or problems impact work, things at home, or relationships with other people. Patient
responses can be one of four: Not difficult at all, Somewhat difficult, Very difficult, Extremely
difficult. The last two responses suggest that the patient’s functionality is impaired. After
treatment begins, functional status and number score can be measured to assess patient
improvement.

For more information on using the PHQ-9, visit www.depression-primarycare.org


QUESTIONNAIRE SUR LA SANTÉ DU
PATIENT-9
(PHQ-9)
Au cours des deux dernières semaines, à quelle
fréquence avez-vous été dérangé(e) par les problèmes Plus de Presque
suivants? Plusieurs sept tous les
(Utilisez un « 9 » pour indiquer votre réponse) Jamais jours jours jours

1. Peu d’intérêt ou de plaisir à faire des choses 0 1 2 3

2. Se sentir triste, déprimé(e) ou désespéré(e) 0 1 2 3

3. Difficultés à s’endormir ou à rester endormi(e), ou trop


0 1 2 3
dormir

4. Se sentir fatigué(e) ou avoir peu d’énergie 0 1 2 3

5. Peu d’appétit ou trop manger 0 1 2 3

6. Mauvaise perception de vous-même — ou vous pensez


que vous êtes un perdant ou que vous n’avez pas satisfait 0 1 2 3
vos propres attentes ou celles de votre famille

7. Difficultés à se concentrer sur des choses telles que lire le


0 1 2 3
journal ou regarder la télévision

8. Vous bougez ou parlez si lentement que les autres


personnes ont pu le remarquer. Ou au contraire — vous
0 1 2 3
êtes si agité(e) que vous bougez beaucoup plus que
d’habitude

9. Vous avez pensé que vous seriez mieux mort(e) ou pensé


0 1 2 3
à vous blesser d’une façon ou d’une autre

FOR OFFICE CODING 0 + ______ + ______ + ______


=Total Score: ______

Si vous avez coché au moins un des problèmes nommés dans ce questionnaire, répondez à la
question suivante : dans quelle mesure ce(s) problème(s) a-t-il (ont-ils) rendu difficile(s) votre
travail, vos tâches à la maison ou votre capacité à bien vous entendre avec les autres?

Pas du tout Plutôt Très Extrêmement


difficile(s) difficile(s) difficile(s) difficile(s)
… … … …

rs
Mis au point par les D Robert L. Spitzer, Janet B. Williams et Kurt Kroenke et collègues, et une bourse d’étude de Pfizer
Inc. Aucune permission requise pour reproduire, traduire, afficher or distribuer.

You might also like